Neoadjuvant vs Adjuvant Chemotherapy in Resected Ampullary Carcinoma: A Propensity-Matched Cohort Analysis
Kerekes D, Frey A, Becher R, Khan S. Neoadjuvant vs Adjuvant Chemotherapy in Resected Ampullary Carcinoma: A Propensity-Matched Cohort Analysis. Journal Of The American College Of Surgeons 2022, 235: s248-s249. DOI: 10.1097/01.xcs.0000894956.83552.8d.Peer-Reviewed Original Research